Institute Rosell-Lallemand

Lallemand Health Solutions is a global leader in the probiotic industry, specializing in the research, development, and manufacturing of probiotic formulations for human health. Founded as Institut Rosell in 1934 and later acquired by the Lallemand Group, the company offers a wide range of documented probiotic strains used in dietary supplements and pharmaceutical applications. Their expertise spans from strain selection and fermentation to finished product formulation, with a strong focus on therapeutic areas such as gastrointestinal health, natural immunity, and the gut-brain axis. The company operates several GMP-certified production facilities and maintains extensive academic collaborations to validate the efficacy of its probiotic solutions, including the pioneering work in psychobiotics.